ArticleBone marrow transplantation2021

Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.

Teresa Lopes Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.